| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |